What 10 Analyst Ratings Have To Say About RxSight
What 10 Analyst Ratings Have To Say About RxSight
10 位分析師評級對 RxSight 有何看法
Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on RxSight (NASDAQ:RXST) in the last three months.
在過去三個月中，有10位分析師公佈了RxSight（納斯達克股票代碼：RXST）的評級，提供了從看漲到看跌的不同視角。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $65.6, a high estimate of $75.00, and a low estimate of $54.00. Observing a 19.03% increase, the current average has risen from the previous average price target of $55.11.
分析師通過對12個月目標股價的評估提供了更深入的見解，顯示平均目標價爲65.6美元，最高估計爲75.00美元，低估值爲54.00美元。目前的平均價格上漲了19.03％，已從之前的平均目標價55.11美元上漲。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析師評級：深度探索
An in-depth...
對分析...
登入免費觀看全文
登入/註冊